Hepion Pharmaceuticals, Inc.
USD0.06
+0.01 (+8.93%)
CEO
Gary S. Stetz
IPO Date
2014-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.06
Prev. Close
$0.06
Day Low
$0.06
Day High
$0.06
52W Low
$0.03
52W High
$0.25
Market Cap
$0.00B
Volume
0.00M
| $0.00 |
| 26 May 2026 | LoPriore Chase | director | Disposed | 0 | $0.00 |
| 27 Apr 2026 | Purcell Michael J. | director | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 27 Apr 2026 | LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | P-Purchase | Acquired | 5,000,000 | $0.04 |
| 27 Apr 2026 | LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 27 Apr 2026 | Appajosyula Sireesh | director | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 27 Apr 2026 | Stetz Gary S. | director, officer: Interim CEO | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 18 Mar 2026 | Stetz Gary S. | director, officer: Chief Executive Officer | Disposed | 0 | $0.00 |
| 18 Mar 2026 | LoPriore Vincent S | director, officer: Executive Chairman | Disposed | 0 | $0.00 |